Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Segments of Business - Schedule of Revenues and Operating Income (loss) by Segment (Details) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Jun. 30, 2017	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Revenue	$ 10,725,365	$ 10,765,317	$ 20,625,315	$ 31,350,678	$ 41,432,863	$ 41,702,001
Operating Income (Loss):	$ (1,398,442)	$ (1,081,455)	$ (2,070,842)	$ (3,469,285)	(5,235,377)	(2,619,888)
Depreciation and Amortization					2,282,801	2,341,697
Operating Segments [Member]
Revenue					41,432,863	41,702,001
Operating Income (Loss):					(5,235,377)	(2,619,888)
Depreciation and Amortization					2,282,801	2,341,697
Operating Segments [Member] \| Hooters Full Service [Member]
Revenue					13,508,220	13,328,809
Operating Income (Loss):					(1,188,598)	116,843
Depreciation and Amortization					496,996	534,210
Operating Segments [Member] \| Better Burgers Fast Casual [Member]
Revenue					22,764,571	22,588,557
Operating Income (Loss):					(537,971)	(372,401)
Depreciation and Amortization					1,459,527	1,481,005
Operating Segments [Member] \| Just Fresh Fast Casual [Member]
Revenue					5,060,072	5,684,635
Operating Income (Loss):					(256,319)	(33,529)
Depreciation and Amortization					322,904	323,108
Operating Segments [Member] \| Corporate and Other [Member]
Revenue					100,000	100,000
Operating Income (Loss):					(3,252,489)	(2,330,801)
Depreciation and Amortization					$ 3,374	$ 3,374